Tenax Therapeutics, Inc. Share Price
NASDAQ: TENXHealthcare
Live Tenax Therapeutics, Inc. Share Price Chart
O H L
Tenax Therapeutics, Inc. Performance Overview
Days Range
▼
$1.87Low
$1.94High
Markets Today
| Previous Close | $1.86 |
|---|---|
| Open | $1.92 |
| Volume | 1,091,570 |
| Day's Range | $1.87 - $1.94 |
| 52W Range | $1.31 - $19.40 |
| Market Cap | $68.11 M |
Historical Performance
| 1M Returns | +9.41 |
|---|---|
| 3M Returns | -84.50 |
| 6M Returns | -88.05 |
| 1Y Returns | -70.98 |
| 5Y Returns | -99.92 |
| 10Y Returns | -100.00 |
Tenax Therapeutics, Inc. Fundamentals
| Market Cap | $68.11 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.56 |
| EPS TTM | $-1.48 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.51 |
| EBITDA | $-56.38 M |
| Profit Margin | N/A |
| Market Cap | $68.11 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.56 |
| EPS TTM | $-1.48 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.51 |
| EBITDA | $-56.38 M |
| Profit Margin | N/A |
Tenax Therapeutics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$11.34 M | -$11.79 M | -$16.81 M | -$16.45 M | -$16.57 M | -$18.78 M |
| EBITDA | -$11.34 M | -$11.79 M | -$16.81 M | -$16.45 M | -$16.57 M | -$18.78 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $0 | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$10.41 M | -$10.85 M | -$15.80 M | -$15.54 M | -$15.72 M | -$17.80 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$10.41 M | -$10.85 M | -$15.80 M | -$15.54 M | -$15.72 M | -$17.80 M |
| Net Profit Margin | - | - | - | - | - | - |
Tenax Therapeutics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $0 | $0 | $1.00 K | $1.00 K | $2.00 K | $3.00 K |
| Reserve & Surplus | -$325.26 M | -$336.11 M | -$351.91 M | -$367.45 M | -$383.17 M | -$400.97 M |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Liabilities | $2.77 M | $2.53 M | $6.60 M | $7.16 M | $8.49 M | $8.07 M |
| Total Liabilities | $2.77 M | $2.53 M | $6.60 M | $7.16 M | $8.49 M | $8.07 M |
| Fixed Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Assets | $112.06 M | $105.86 M | $102.81 M | $104.23 M | $123.18 M | $121.66 M |
| Total Assets | $112.06 M | $105.86 M | $102.81 M | $104.23 M | $123.18 M | $121.66 M |
Tenax Therapeutics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$10.41 M | -$10.85 M | -$15.80 M | -$15.54 M | -$15.72 M | -$17.80 M |
| Operating Cash Flow | -$6.97 M | -$6.26 M | -$9.15 M | -$13.41 M | -$9.31 M | -$14.15 M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $23.56 M | $278.00 K | $3.06 M | $11.61 M | $30.50 M | $13.37 M |
| Change in Cash | $16.60 M | -$5.99 M | -$6.09 M | -$1.80 M | $21.19 M | -$779.00 K |
Tenax Therapeutics, Inc. Return Calculator
The Tenax Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$8
Invested Amount$10,000
Est. Returns$-9,992
About Tenax Therapeutics, Inc.
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Popular Stocks
FAQs
What is the share price of Tenax Therapeutics, Inc. today?
Tenax Therapeutics, Inc. (TENX) share price as of September 18, 2026 is $1.86. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Tenax Therapeutics, Inc.?
Yes, Indian Investors can invest in the Tenax Therapeutics, Inc. (TENX) Share by opening an international trading account with Angel One.
How can I purchase Tenax Therapeutics, Inc. shares in India?
Purchasing Tenax Therapeutics, Inc. (TENX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Tenax Therapeutics, Inc. (TENX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Tenax Therapeutics, Inc.?
Yes, you can purchase fractional shares of Tenax Therapeutics, Inc. (TENX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Tenax Therapeutics, Inc.?
The market capitalization of Tenax Therapeutics, Inc. on September 18, 2026, is $68.11 M.
In which sector Tenax Therapeutics, Inc. belongs?
Tenax Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Tenax Therapeutics, Inc. stocks?
In order to invest in Tenax Therapeutics, Inc. (TENX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
